Skip to Main Content


Pamela L. Kunz, MD

Associate Professor of Internal Medicine (Medical Oncology); Director, Center for Gastrointestinal Cancers at Smilow Cancer Hospital and Yale Cancer Center; Chief, GI Medical Oncology; Vice Chief, Diversity, Equity, and Inclusion, Medical Oncology



Dr. Kunz specializes in the treatment of gastrointestinal malignancies. Her research involves clinical trials and epidemiologic studies, primarily in neuroendocrine and gastroesophageal cancers. She is an international leader in the clinical care of patients with neuroendocrine tumors (NETs) and is advancing the field through clinical trials and translational science that are defining the next generation of therapies for patients with this rare diagnosis. She is the current president of the North American Neuroendocrine Tumor Society (NANETS).

Learn more about Dr. Kunz >>

Education & Training

  • Oncology Fellow
    Stanford University (2008)
  • Chief Resident
    Stanford University (2005)
  • Internal Medicine Resident
    Stanford University (2004)
  • MD
    Dartmouth Medical School (2001)
  • BA
    Dartmouth College, Biology (1994)

Departments & Organizations